Develops biopharmaceutical and non-pharmaceutical products using microbial cells.
Jun 2026Revenue $3.80M/yrExpenses $11.2M/yr
No trendCash runway ≈ 5 months from Jun 2026
Figures by year
When will Dyadic International be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $3.80M and expenses $11.2M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $3.09M | $10.3M | −$7.19M |
| Dec 2024 | $3.50M | $9.40M | −$5.90M |
| Dec 2023 | $2.90M | $11.1M | −$8.23M |
| Dec 2022 | $2.93M | $13.1M | −$10.2M |
| Dec 2021 | $2.40M | $17.1M | −$14.7M |
| Dec 2020 | $1.60M | $11.6M | −$10.0M |
| Dec 2019 | $1.68M | $11.0M | −$9.28M |
| Dec 2018 | $1.30M | $8.89M | −$7.59M |
| Dec 2017 | $758K | $7.89M | −$7.13M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.